Home » Newsletters » BioWorld Science

BioWorld Science

April 9, 1998

View Archived Issues

CombiChem and Icos announce drug discovery collaboration

Mitotix describes novel inhibitors of the CDK/cyclin complexes

NPY Y1 receptor ligands for eating and cardiovascular disorders

New COX-2-selective compounds in development at Merck Frosst

Novel GH secretagogues disclosed by Novo Nordisk

MS&D describes novel class of antimigraine agents

EGFR tyrosine kinase inhibitor from Novartis will proceed to clinical testing

Chemistry of new immunosuppressive triterpenoid elucidated by Merck & Co.

Flk-1/KDR receptor tyrosine kinase inhibitor SU-5416 characterized at ACS meeting

New agents for BPH emerge from Synaptic/Merck & Co. collaboration

VIMRx and Columbia U. form new drug discovery and development company

Interneuron receives fast track designation for CerAxon

TNFR:Fc evaluated clinically for congestive heart failure

Cytovia raises USD 10 million for development and commercialization of proprietary technology

Pharmacokinetic/safety results reported from ongoing phase I trial of Spartaject busulfan

Cyclic depsipeptide from Streptomyces induces apoptosis in tumor cells

Klinge identifies new apoptosis inducers active against MDR cell lines

Chinese scientists discover novel antitumor antibiotic

Hokuriku Seiyaku seeks development partners for novel antihistamine

New cell therapy developed at Wistar Institute shows potential as chemotherapy adjuvant

PKCbeta inhibitor from Lilly may potentiate effects of radio- and chemotherapy

Mechanism of cytotoxic effect of ImmTher

Aplidine evaluated for activity in animal models of lymphoma, prostate and gastric cancer

Popular Stories

Today's news in brief
BioWorld
SCAN is core circuit affected in Parkinson’s disease
BioWorld Science
Parkinson’s disease (PD) is a neurodegenerative disorder that affects movement, and tremor is one of its signatures. But it is a much more wide-ranging disorder,...
TL1A is overexpressed in hidradenitis suppurativa
BioWorld Science
Despite the availability of advanced therapeutic options, about 40%-50% of patients with hidradenitis suppurativa do not achieve significant improvement in...
IL-22 and TL1A, a robust couple for diagnosing hidradenitis suppurativa
BioWorld Science
Hidradenitis suppurativa (HS) is a chronic inflammatory skin disease with strong association with psoriasis and inflammatory bowel disease (IBD). While some...
Astellas’ ASP-2246 shows promise in stroke management
BioWorld Science
Astellas Pharma Inc. recently presented data regarding ASP-2246, a drug candidate comprised of an mRNA encoding the transcription factor NeuroD1 encapsulated in...